Cargando…

Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery

BACKGROUND: Antithrombotic drugs, including the P2Y(12) inhibitor ticagrelor, increase the risk of perioperative bleeding in patients requiring urgent cardiac surgery. Perioperative bleeding can lead to increased mortality and prolong intensive care unit and hospital stays. A novel sorbent-filled he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Benjamin G., Chingcuanco, Francine, Zhang, Jingwei, Reid, Natalie M., Lee, Victoria, Hong, Jonathan, Deliargyris, Efthymios N., Padula, William V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328880/ https://www.ncbi.nlm.nih.gov/pubmed/37204675 http://dx.doi.org/10.1007/s40256-023-00587-4

Ejemplares similares

Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery—a systematic review
por: Matejic-Spasic, Marijana, et al.
Publicado: (2022)

Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
por: Hassan, Kambiz, et al.
Publicado: (2023)

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis
por: Padula, W., et al.
Publicado: (2020)

Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent
por: Tripathi, Ritu, et al.
Publicado: (2022)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens
por: Albabtain, Monirah A, et al.
Publicado: (2022)

Ticagrelor Removal From Human Blood
por: Angheloiu, George O., et al.
Publicado: (2017)

Major gastrointestinal bleeding and antithrombotics: Characteristics and management
por: Bouget, Jacques, et al.
Publicado: (2020)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA
por: Gil, Hyun-Il, et al.
Publicado: (2021)

The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome
por: Liu, Zhengwang, et al.
Publicado: (2022)

Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk
por: Matsuura, Yunosuke, et al.
Publicado: (2022)

The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock
por: Hawchar, Fatime, et al.
Publicado: (2021)

New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
por: Honore, Patrick M., et al.
Publicado: (2020)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Retracted: The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Effect of Antithrombotic Therapy on Secondary Bleeding After Proctological Surgery
por: Maemoto, Ryo, et al.
Publicado: (2021)

An algorithmic approach to gastrointestinal bleeding in patients receiving antithrombotic agents
por: Sadeghi, Amir, et al.
Publicado: (2020)

The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection
por: Takeuchi, Toshihisa, et al.
Publicado: (2013)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
por: Kim, Byung Gyu, et al.
Publicado: (2021)

Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wang, He-Yang, et al.
Publicado: (2018)

Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
por: Bastiany, Alexandra, et al.
Publicado: (2018)

Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial
por: Cho, Jae Young, et al.
Publicado: (2021)

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Cessation of antithrombotic therapy before surgery: weighing thrombosis and bleeding risks
por: Meesters, M. I., et al.
Publicado: (2014)

Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics
por: Fujikawa, Takahisa, et al.
Publicado: (2017)

Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
por: Nishtala, Prasad S., et al.
Publicado: (2019)

Meta-analysis of the effect of antithrombotic drugs on perioperative bleeding in BPH surgery
por: He, Qian, et al.
Publicado: (2020)

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
por: Kessler, Chiara, et al.
Publicado: (2020)

Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment
por: AlSheef, Mohammed, et al.
Publicado: (2021)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Management of antithrombotic agents in patients undergoing flexible bronchoscopy
por: Abuqayyas, Sami, et al.
Publicado: (2017)

Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy–An observational study
por: Holm, Anna, et al.
Publicado: (2021)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Increased Cerebral Small Vessel Disease Burden With Renal Dysfunction and Albuminuria in Patients Taking Antithrombotic Agents: The Bleeding With Antithrombotic Therapy 2
por: Tanaka, Kanta, et al.
Publicado: (2022)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost
por: Cao, Davide, et al.
Publicado: (2021)

Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk
por: Park, Keun-Ho, et al.
Publicado: (2021)

Next-generation antithrombotics in ischemic stroke: preclinical perspective on ‘bleeding-free antithrombosis'
por: Kraft, Peter, et al.
Publicado: (2012)

Clinical outcome of patients with obscure gastrointestinal bleeding during antithrombotic drug therapy
por: Kono, Yoshiyasu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0lis959jfcbisgfp59j2ttltgb